# LAMIVUDINE
> **ANDA203564** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2014-10-31
## Drug
- **FDA Application Number:** ANDA203564
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** LAMIVUDINE ORAL
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL MOLECULAR
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2014-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203564)
---
*AI Analytics · CC0 1.0*